Copyright © 2002 by the European Society of Cardiology.
Urate predicts subsequent cardiac death in stroke survivors
a The Cardiovascular Research Group, Department of Clinical Pharmacology & Therapeutics, University of Dundee Medical School, Ninewells Hospital, Dundee, U.K.
b Stroke Studies Centre, Department of Medicine, University of Dundee Medical School, Ninewells Hospital, Dundee, U.K.
c Epidemiology & Public Health, University of Dundee Medical School, Ninewells Hospital, Dundee, U.K.
revised August 7, 2001; accepted August 15, 2001
Abstract
Aims To test the hypothesis that urate predicts cardiac death after stroke independent of conventional risk factors of atherosclerosis, creatinine and diuretic use.
Methods and Results Serum urate concentration was measured in an unselected cohort of 354 stroke survivors who were followed-up for a median of 2·8 years. Cardiac death was the primary end-point. Urate was associated with a statistically significant threefold increase in relative risk of cardiac death even after adjustment for other conventional risk factors. In the subgroup of patients who were not on diuretics, raised urate was associated with a 12-fold significant increase in relative risk of cardiac death after adjusting for renal function and other conventional risk factors. A urate concentration of greater than 0·31mmol.l1 was 78% sensitive at predicting cardiac death within 5 years after stroke, but was only 54% specific. If urate exceeded 0·38mmol.l1, specificity of predicting cardiac death within 5 years after stroke was 88%.
Conclusions Elevated serum urate concentration may be used to stratify risk of future cardiac death after stroke. This appeared to be true even in stroke survivors who were not on diuretic therapy.
Key Words: Urate, stroke, cardiac death
f1 Correspondence: Dr Kenneth Wong, The Cardiovascular Research Group, Department of Clinical Pharmacology & Therapeutics, Ninewells Hospital, Dundee DD1 9SY, U.K.
References
- Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke. 1993;24:796800
[Abstract/Free Full Text] - Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators [published errata appear in N Engl J Med 2000 Mar 9;342(10):748 and 2000 May 4;342(18):1376]. N Engl J Med. 2000;342:145153
[Abstract/Free Full Text] - Dobson A. Is raised serum uric acid a cause of cardiovascular disease or death? Lancet. 1999;354:1578[CrossRef][ISI][Medline]
- Kohn PM, Prozan GB. Hyperuricaemia: relationship to hypercholesterolaemia and acute myocardial infarction. JAMA. 1959;170:19091915[ISI][Medline]
- Beard JT. Serum uric acid and coronary heart disease. Am Heart J. 1983;106:397400[CrossRef][ISI][Medline]
- Liese AD, Hense HW, Lowel H, Doring A, Tietze M, Keil U. Association of serum uric acid with all-cause and cardiovascular disease mortality and incident myocardial infarction in the MONICA Augsburg cohort. World Health Organization Monitoring Trends and Determinants in Cardiovascular Diseases. Epidemiology. 1999;10:391397[CrossRef][ISI][Medline]
- Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non- insulin-dependent diabetes mellitus. Stroke. 1998;29:635639
[Abstract/Free Full Text] - Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:713
[Abstract/Free Full Text] - Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart. 1997;78:147153
[Abstract/Free Full Text] - Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation. 1999;100:354360
[Abstract/Free Full Text] - Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11·5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol. 1989;42:257267[CrossRef][ISI][Medline]
- Ward HJ. Uric acid as an independent risk factor in the treatment of hypertension [published erratum appears in Lancet 1998 Sep 12;352(9131):912]. Lancet. 1998;352:670671[CrossRef][ISI][Medline]
- Castelli P, Condemi AM, Brambillasca C. Improvement of cardiac function by allopurinol in patients undergoing cardiac surgery. J Cardiovasc Pharmacol. 1995;25:119125[ISI][Medline]
- De Scheerder IK, van de Kraay AM, Lamers JM, Koster JF, de Jong JW, Serruys PW. Myocardial malondialdehyde and uric acid release after short-lasting coronary occlusions during coronary angioplasty: potential mechanisms for free radical generation. Am J Cardiol. 1991;68:392395[CrossRef][ISI][Medline]
- Muscelli E, Natali A, Bianchi S. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens. 1996;9:746752[CrossRef][ISI][Medline]
- Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ. 1995;310:560564
[Abstract/Free Full Text] - Selby JV, Friedman GD, Quesenberry CP Jr. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries [published erratum appears in Am J Epidemiol 1990 Sep;132(3):589]. Am J Epidemiol. 1990;131:10171027
[Abstract/Free Full Text] - Waring WS, Webb DJ, Maxwell SRJ. Effect of local hyperuricaemia on endothelial function in the human forearm vascular bed. Br J Clin Pharmacol. 2000;49:511P
- Britten MB, Elsner M, Walter DH, Schachinger V. Elevated uric acid levels in hypercholesterolaemia are associated with coronary endothelial dysfunction (Abstr). Circulation. 1999;100:6
- Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J. 1999;340:143152
- Boogaerts MA, Hammerschmidt DE, Roelant C, Verwilghen RL, Jacob HS. Mechanisms of vascular damage in gout and oxalosis: crystal induced, granulocyte mediated, endothelial injury. Thromb Haemost. 1983;50:576580[ISI][Medline]
- Duff GW, Atkins E, Malawista SE. The fever of gout: urate crystals activate endogenous pyrogen production from human and rabbit mononuclear phagocytes. Trans Assoc Am Physicians. 1983;96:234245[Medline]
- Hutton CW, Collins AJ, Chambers RE, Whicher J, Dieppe PA. Systemic response to local urate crystal induced inflammation in man: a possible model to study the acute phase response. Ann Rheum Dis. 1985;44:533536
[Abstract/Free Full Text] - Leyva F, Anker SD, Godsland IF. Uric acid in chronic heart failure: a marker of chronic inflammation. Eur Heart J. 1998;19:18141822
[Abstract/Free Full Text] - Falasca GF, Ramachandrula A, Kelley KA, O'Connor CR, Reginato AJ. Superoxide anion production and phagocytosis of crystals by cultured endothelial cells. Arthritis Rheum. 1993;36:105116[ISI][Medline]
- Waring WS, Webb DJ, Maxwell SRJ. Uric acid as a risk factor for cardiovascular disease. Q J Med. 2000;93:707713
- Patetsios P, Rodino W, Wisselink W, Bryan D, Kirwin JD, Panetta TF. Identification of uric acid in aortic aneurysms and atherosclerotic artery. Ann NY Acad Sci. 1996;800:243245[ISI][Medline]
- Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2000;35:746751
[Abstract/Free Full Text] - Cardillo C, Kilcoyne CM, Cannon RO III, Quyyumi AA, Panza JA. Xanthine oxidase inhibition with oxypurinol improves endothelial vasodilator function in hypercholesterolemic but not in hypertensive patients. Hypertension. 1997;30:5763
[Abstract/Free Full Text] - Farquharson C, Butler RA, Hill A, Belch JJF, Struthers AD. Allopurinol improves endothelial dysfunction in chronic heart failure. J Am Coll Cardiol. 1999;33:216A
- Pan WH, Chin CJ, Sheu CT, Lee MH. Hemostatic factors and blood lipids in young Buddhist vegetarians and omnivores. Am J Clin Nutr. 1993;58:354359
[Abstract/Free Full Text]
This article has been cited by other articles:
![]() |
A. Fournier, O. Godefroy, R. Oprisiu, M. Slama, M. Andrejak, R. S. MacWalter, K. Y.K. Wong, S. Y.S. Wong, A. D. Struthers, and Y. Ersoy Converting Enzyme Inhibitor or AT1-Receptor Blocker for Decreasing Long-Term Mortality in Patients With Stroke History and Renal Dysfunction? Stroke, January 1, 2003; 34(1): 8 - 9. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
